OTC · Drug Manufacturers - General

Otsuka Holdings Co., Ltd. (OTSKY) Stock

$33.72 -1.23% OTC: OTSKY Healthcare

Otsuka Holdings Co., Ltd. engages in the management of its group companies which are in the pharmaceuticals business.

Valuation

MetricValue
Price$33.72
Market Cap$35.56B
P/E Ratio15.46
P/B Ratio1.87
P/S Ratio2.30
EPS (TTM)$2.18
52-Week High$37.52
52-Week Low$21.68
Dividend Yield1.28%

Financials & Margins

MetricValue
ROE12.85%
ROA8.94%
ROCE11.43%
Gross Margin71.52%
Operating Margin16.00%
Net Margin14.96%
Debt/Equity0.06
Current Ratio2.33

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.50T$1.74T$2.02T$2.33T$2.59T
Operating Profit$154.5B$150.3B$139.6B$323.6B$432.4B
Net Profit$125.5B$133.9B$121.6B$343.1B$380.8B
EPS$115.58$123.40$112.05$316.88$359.19
Op Margin10.3%8.7%6.9%13.9%16.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.82T$3.10T$3.36T$3.74T$4.20T
Total Liabilities$775.7B$840.2B$924.9B$961.1B$1.10T
Cash$410.7B$471.6B$513.3B$426.2B$535.0B
Borrowings$212.5B$194.2B$214.2B$189.4B$228.0B

Latest News

FDA Fast-Tracks Review of Some Psychedelic Drugs. This Stock Is Set to Benefit. Barrons.com · Apr 24, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$228.9B$211.8B$283.2B$354.6B$423.1B
Investing Cash Flow$-208.4B$-189.4B$-305.2B$-395.2B$-261.5B
Financing Cash Flow$-18.9B$-19.8B$-20.6B$-75.5B$-100.4B
Net Cash Flow$53.8B$61.0B$41.7B$-87.2B$109.7B
Free Cash Flow$115.7B$104.1B$168.6B$225.3B$331.0B

Valuation & Return Ratios

MetricValue
PEG Ratio1.61
EV / EBITDA9.20
FCF Yield5.42%
Quick Ratio1.76
Interest Coverage26.27
Return 1Y48.91%
Return 3Y83.19%
Return 5Y73.81%

Ownership

Insiders Held0.00%
Institutions Held0.32%
Institutions Float Held0.32%
Institutional HolderSharesReport Date
Aristotle Capital Management, LLC3,087,9782026-03-31
Hantz Financial Services, Inc. 77,9902026-03-31
Boston Common Asset Management, LLC82,8602026-06-30
First Command Advisory Services, Inc.1892026-03-31
PNC Financial Services Group, Inc.1022026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALPMFAstellas Pharma Inc. $12.85 +0.00% 13.19 $23.02B 3.81%
ALPMYAstellas Pharma Inc. $13.13 -0.68% 13.19 $23.52B 3.12%
BAYRYBayer AG $14.28 -1.11% -22.74 $56.12B 0.21%
FSNUFFresenius SE & Co. KGaA $54.35 +0.00% 15.70 $30.61B 2.24%
GIKLYGrifols, S.A. $5.10 +0.00% 14.79 $13.40B 0.98%

About Otsuka Holdings Co., Ltd.

Otsuka Holdings Co., Ltd. engages in the management of its group companies which are in the pharmaceuticals business. It operates through the following segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan.

Otsuka Holdings Co., Ltd. is headquartered in JP.

Otsuka Holdings Co., Ltd. (OTSKY) stock trades at $33.72 with a market capitalization of $35.56B. The stock is valued at a price-to-earnings (P/E) ratio of 15.46, price-to-book of 1.87, price-to-sales of 2.30. Over the past 52 weeks the stock has ranged between $21.68 and $37.52, and currently trades 10.1% below its 52-week high. It pays a dividend yielding 1.28%.

On profitability, Otsuka Holdings Co., Ltd. generates a return on equity (ROE) of 12.85%, above the typical market average, return on capital employed of 11.43%, an operating margin of 16.00%, a net profit margin of 14.96%.

In its most recent fiscal year, Otsuka Holdings Co., Ltd. reported annual revenue of $2.59T, net profit of $380.8B, revenue has compounded at 12.7% a year over the last five years, profit at 20.8% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.06 — a conservative balance sheet with little leverage risk, a current ratio of 2.33, total assets of $4.20T, $535.0B in cash and equivalents.

OTSKY has an average daily trading volume of 42,686 shares, a beta of -0.05 (less volatile than the overall market).

Official website: www.otsuka.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides